Kenya - Kiingereza - Pharmacy and Poisons Board

abacus pharma (a) ltd. p.o.box: 66829-00800 nairobi kenya - paracetamol aspirin caffeine - tablet - paracetamol-250mg aspirin-300mg caffeine… - non-steroidal

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

seven seas ltd - ascorbic acid - tablets effervescent - 500 milligram

Marekani - Kiingereza - NLM (National Library of Medicine)

harmony biosciences, llc - pitolisant hydrochloride (unii: yv33ch63hi) (pitolisant - unii:4bc83l4piy) - wakix is indicated for the treatment of excessive daytime sleepiness (eds) or cataplexy in adult patients with narcolepsy. wakix is contraindicated in patients with: - known hypersensitivity to pitolisant or any component of the formulation. anaphylaxis has been reported in patients treated with wakix [see adverse reactions (6.2)] . - severe hepatic impairment. wakix is extensively metabolized by the liver and there is a significant increase in wakix exposure in patients with moderate hepatic impairment [see use in specific populations (8.6)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women who are exposed to wakix during pregnancy. patients should be encouraged to enroll in the wakix pregnancy registry if they become pregnant. to enroll or obtain information from the registry, patients can call 1-800-833-7460. risk summary available case reports from clinical trials and postmarketing reports with wakix use in pregnant women have not determined a d

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

seven seas ltd - ascorbic acid - tablets effervescent - 500 milligram